CDK4 and melanoma: In MMTV-Erbb2 breast, MC38 colon, and B16-F10 melanoma tumor models, CDK4/6 inhibition led to a decrease in total numbers of CD3+ tumor infiltrating T cells, encompassing CD8+ T cells and Granzyme B+ and IFNγ+ cells (110).